Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

252.87 -2.45 (-0.96%)

Official Closing Price Updated: 7:00 PM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

2 Stocks That Could Grow Your Portfolio Over the Next Decade ↗

August 15, 2023

These two promising stocks could help your portfolio grow steadily over the long term.

Via The Motley Fool

The Latest Analyst Ratings for ResMed ↗

August 14, 2023

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,000 Today ↗

August 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 04, 2023

On Friday, 73 companies reached new 52-week lows.

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

ResMed's Earnings: A Preview ↗

August 02, 2023

Via Benzinga

ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry ↗

August 04, 2023

ResMed Inc (NYSE: RMD) posted Q4 adjusted EPS of $1.60, up from $1.49 a year ago, missing the consensus of $1.67.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 04, 2023

Via Benzinga

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Here's How Much You Would Have Made Owning ResMed Stock In The Last 5 Years ↗

July 28, 2023

Via Benzinga

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023

August 03, 2023

From ResMed Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023 ↗

August 01, 2023

Via Benzinga

Looking Into ResMed's Recent Short Interest ↗

July 26, 2023

Via Benzinga

Here's How Much $100 Invested In ResMed 20 Years Ago Would Be Worth Today ↗

July 11, 2023

Via Benzinga

Peering Into ResMed's Recent Short Interest ↗

July 10, 2023

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today ↗

June 28, 2023

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today ↗

June 12, 2023

Via Benzinga

Here's How Much You Would Have Made Owning ResMed Stock In The Last 10 Years ↗

May 26, 2023

Via Benzinga

ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023

July 06, 2023

From ResMed Inc.

Via GlobeNewswire

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

July 05, 2023

From ResMed Inc.

Via GlobeNewswire

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

June 08, 2023

From ResMed Inc.

Via GlobeNewswire

A Bullish Sign Appears On ResMed's Chart ↗

May 17, 2023

Via Benzinga

ResMed Earnings Perspective: Return On Capital Employed ↗

May 03, 2023

Via Benzinga

ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference

June 05, 2023

From ResMed Inc.

Via GlobeNewswire

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

May 25, 2023

From ResMed Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023 ↗

May 22, 2023

Via Benzinga

Electronic Arts, TD SYNNEX And 2 Other Stocks Insiders Are Selling ↗

May 15, 2023

The Nasdaq index closed lower on Friday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer

May 02, 2023

From ResMed Inc.

Via GlobeNewswire

What's Going On With ResMed Stock Today ↗

April 28, 2023

ResMed Inc (NYSE: RMD) posted Q3 profits of $247.8 million, with adjusted EPS of $1.68, up from $1.32 a year ago, beating the consensus of $1.59. Revenues increased 29% to $1.12 billion, as continued...

Via Benzinga

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023

April 27, 2023

Year-over-year revenue grows 29%, operating profit up 28%, non-GAAP operating profit up 27%

From ResMed Inc.

Via GlobeNewswire

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.